Skip to main content
IP Group PLC logo

IP Group PLC — Investor Relations & Filings

Ticker · IPO ISIN · GB00B128J450 LEI · 213800HG22UM138WFG43 IL Financial and insurance activities
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2017-12-31 Annual Report
Country GB United Kingdom
Listing IL IPO

About IP Group PLC

https://www.ipgroupplc.com/

IP Group PLC is an intellectual property commercialization firm that specializes in creating, building, and supporting early-stage, science-based businesses. The company provides capital, expertise, and strategic guidance to innovators, helping to transform groundbreaking research into tangible impact. Its investment portfolio is focused on three core sectors: life sciences, aimed at curing and preventing disease; deeptech, focused on developing disruptive technologies for digital resilience and new capabilities; and cleantech, which supports scalable solutions to address climate change. By partnering with scientists and entrepreneurs, IP Group works to develop defensible innovations with the potential to address significant global challenges, aiming to deliver both strong financial returns and positive societal impact.

Recent filings

Filing Released Lang Actions
IP Group plc - 2017 Annual Report
Annual Report Classification · 100% confidence The document is titled 'IP Group plc Annual Report and Accounts for the year ended 31 December 2017'. It contains comprehensive financial statements, a strategic report, governance information, and auditor's reports, which are characteristic of a full annual report. It is not an announcement or a summary, but the primary document itself. FY 2017
2017-12-31 English
Autifony signs Eur627.5m agreement with BI
M&A Activity Classification · 99% confidence The document begins with an 'RNS Number' and the date '18 December 2017', indicating it is a regulatory announcement disseminated via the Regulatory News Service (RNS). The content details a significant business event: a collaboration agreement and option deal between IP Group's portfolio company (Autifony) and Boehringer Ingelheim, including financial terms and strategic implications. This type of material—a press release announcing a major corporate transaction or development that must be disclosed to the market—is typically classified as a general regulatory filing or announcement. Since it is not a full annual report (10-K), an earnings release (ER), a proxy statement (DEF 14A), or a specific transaction report like Director's Dealing (DIRS) or Share Issue (SHA), the most appropriate general category for a mandatory market disclosure disseminated via RNS is 'Regulatory Filings' (RNS). The document length (12,839 chars) is substantial, suggesting it is the primary announcement itself, not just a brief notice of publication (RPA).
2017-12-18 English
Diurnal receives positive CHMP opinion for Alkindi
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement disseminated via the Regulatory News Service (RNS). The content describes a positive opinion received by a portfolio company (Diurnal) regarding a drug application (Alkindi®) from the European Medicines Agency (EMA). This is a specific corporate update related to clinical/regulatory progress, not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Since it is a formal, time-sensitive announcement distributed through the official regulatory channel (RNS) that doesn't fit into the more specific categories like DIV, DIRS, or MANG, the most appropriate classification is the general regulatory announcement category, RNS.
2017-12-15 English
Directorate Change
Board/Management Information Classification · 98% confidence The document is a formal announcement released via 'RNS Number : 4224Z' from IP Group PLC on December 14, 2017. The core content announces the retirement of a non-executive director (Doug Liversidge) and the subsequent appointment of a new Senior Independent Director (Professor David Begg). This type of announcement, detailing changes in the company's board of directors or senior management, directly matches the definition for Board/Management Information (MANG). Although it is an RNS release, the specific content is highly targeted to management changes, making MANG the most precise classification over the general RNS fallback.
2017-12-14 English
Issue of Equity
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number header and contains an 'IP Group plc - Issue of Equity' announcement dated 13 December 2017. It discusses the issuance of new shares following a takeover offer (M&A activity) and provides details on the admission of these shares to the Official List. While it relates to a takeover (TAR), the core announcement is about the resulting capital change (issuance of new shares) and is distributed via the RNS system. Since the document is a formal regulatory announcement detailing a change in the number of shares in issue following a corporate action, it fits best under Capital/Financing Update (CAP) or potentially Share Issue/Capital Change (SHA). Given the context of the offer completion leading directly to the share issuance, SHA is highly specific. However, the document is clearly a regulatory news service announcement (RNS Number, 'FOR IMMEDIATE RELEASE', 'This information is provided by RNS'). Since the primary action described is the issuance of new shares following a corporate event, SHA is the most precise fit for the content, although RNS is the distribution method. I will classify it as SHA as it details the capital change itself, not just the announcement of a report.
2017-12-13 English
Mirriad raises £26.2m; proposed admission to AIM
Share Issue/Capital Change Classification · 99% confidence The document is an official announcement released via RNS (RNS Number : 7933Y) on December 8, 2017. The content details a portfolio company (Mirriad) successfully pricing an Initial Public Offering (IPO) and applying for admission to AIM, including the fundraising amount (£26.2m) and IP Group's resulting stake. This is a specific corporate action announcement related to financing and capital structure changes for a subsidiary, which IP Group is reporting on. While it involves fundraising (CAP), the primary nature of this specific RNS filing is to disseminate news about a significant corporate event (IPO/Admission) via the regulatory news service. Since it is a general regulatory announcement that doesn't fit perfectly into the highly specific categories like DIV, DIRS, or ER, and it is clearly an RNS release, the most appropriate general classification is RNS, although CAP is a close secondary consideration. Given the structure and source (RNS Number), RNS is the best fit for a general regulatory news service release.
2017-12-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.